-100% Net Profit after Extra Items -344 -22 1,464% 239 -244% -105 0.2 -52,600% EPS (Baht/Share) -0.34 -0.02 1,600% 0.23 -248% -0.10 0.0002 -50,100% Note: (1) Adjusted EBITDA refers to EBITDA excluding

, total assets were Baht 2,941 million, increased by Baht 183 million from the balance at the ended of 31 December 2019. This were mainly because the Company acquired share capital from the former

much and still focus on maintaining our market share in domestic market by improving our sales strategy as well as developing new products to meet customer demand and driving to expand the export market

measurements directly affect with the business of Wuttisak Clinic Intergroup Co., Ltd. (“Wuttisak Clinic” or “WCIG” indirect subsidiary, hold share by WCI Holding PCL) to close all branches resulting in lack of

requirement by the Bank of Thailand with the capital adequacy ratio as of end of March 2021 at 16.75%. For Capital market business, the market share (SET and mai excluding proprietary trading) of Kiatnakin

methods of Acquisition/Disposition Remark DV8 PUBLIC COMPANY LIMITED (DV8) Mr. THANARATH THANAVUTWATTHANA Reporter Common Share 23/05/2019 1,300,000 0.45 Purchase Link DV8 PUBLIC COMPANY LIMITED (DV8) Mr

of Food Chain which should not be affected much and still focus on maintaining our market share in domestic market by improving our sales strategy as well as developing new products to meet customer

March 31, 2020 at Baht 0.51 per share, totaling Baht 191,250,000. The schedules are as follows: 1.1 The Record Date to determine the list of shareholders who have the rights to receive the interim

(%) 12.31% 29.10% EPS (Baht/Share) 0.245 0.16 Consolidated financial statement 31 December 2019 Q1/2020 D/E RATIO (Times) 1.15 1.15 Please be informed accordingly Yours sincerely, -Signature- (Miss Nilrat

Liabilities 84.20 376.72 (292.52) -347.42% 1,482.63 1,825.67 (343.03) -23.14% SHAREHOLDERS' EQUITY Issued and paid-up share capital 1,316.25 1,316.25 - 0.00% Premium on ordinary shares 264.33 264.33 - 0.00